Related Image: TrueVision Teams with Ophthalmologists to Help Cure World Blindness for Treatable Cataracts -- Debut of 3D Training Video for Manual, Small-Incision Cataract Surgery |
(Date:11/25/2009)...study follow-up period was too short to draw defin...SDAY, Nov. 25 (HealthDay News) -- In diabetic pati... to be no difference in outcomes at one year wheth...with stenting, British researchers report. , By...iabetic patients with coronary artery disease. How...
(Date:11/25/2009)...ivors often plagued by neurological symptoms, stud...ay News) -- Neurological side effects are among th...of testicular cancer who were treated with cisplat... The study included 1,409 Norwegian men treated fo...94 who took part in a follow-up survey conducted f...
(Date:11/25/2009)..., LittleImprovementShownforthe4thStraightYear ... Today,LungCancerAlliance-Georgia(LCA-GA)issuedth...ssessmentofprogressbeingmadeagainstthislethaldisea...Alliance(LCA),theonlynationalorganizationdedicated...ingwithoratriskforlungcancer. ,, (Logo: http://...
(Date:11/25/2009)...ice, disks placed under the skin kill tumor cells,...lthDay News) -- A cancer vaccine delivered in a fi...n mice, a new study reports. , The method uses ...re loaded with tumor-specific antigens and implant...o attack tumors. The Harvard University scientists...
(Date:11/25/2009)... BioSpace.com, the premier re...nveiled the third edition of the BioForest™ ... Englewood, CO (Vocus) November 25, 2009 -- ...e careers and information, unveiled the third edit...orning., , , , ,This regional campaign is a promo...
Breaking Medicine News(10 mins):Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2Health News:BioSpace Showcases Leading Life-Science Companies in the Northwest 2...f the HIV virus in the UK has come just in time be...n December 1st. This has created panic // among th... second wave epidemic of resistant virus.
Anti... Indinavir, Efavirenz, Nevirapine and Didanosine. ...
...omprehensive study conducted by the scientists at ...archers entered data on climate-sensitive diseases...sions. The WHO data also shows that the worst affe...ofessor at the university's Gaylord Nelson Institu...
...could change the way we treat breast cancer. The n...o help doctors identify breast disease // up to ei...a mammogram.
Breast pap patient Amy Rhoades is...east is quick and painless. Fluid is extracted fro...
...rst human death from bird flu - a 24-year-old farm...n became sick after an outbreak of bird flu among ... Nov 10, // the health ministry said, according to...s most populous country. A 12-year-old girl died O...
...n for losing teeth as is generally known, but ther...isk,' said study author Dr. Khalaf F. Al-Shammari,...may help in educating the public about these facto...Kuwait and Michigan monitored all tooth extraction...
... announced between Elsevier and Diabetes India. Th...ew journal, named Diabetes Research & Metabolic Sy...s on the importance of the relationship between di...Diabetes India originally named as The Indian Task...
Other Medicine News:Health News:Partnership Between Diabetes India And Elsevier Announced 2(Date:11/24/2009)..., IRVINE,Calif.,Nov.24/PRNewswire-FirstCall/--Endo...sivetreatmentsforaorticdisorders,announcedtodaytha...gsin,thepatentinfringementlawsuitbroughtagainstiti...dStatesDistrictCourtinIndianapolis,Indiana. ,, ...etheUnitedStatesPatentandTrademarkOffice(USPTO)con...
(Date:11/24/2009)..., FREMONT,Calif.,Nov.24/PRNewswire-FirstCall/--Ver...mpanyfileditsPlanofReorganizationandDisclosureStat...ruptcyCourtfortheDistrictofDelaware.Ahearingtocons...eduledforDecember8,2009,withthehearingontheconfirm...PlancallsfortheCompanytopayallclaimsinfull.ThePlan...
(Date:11/24/2009)..., WOODCLIFFLAKE,N.J.andNEWYORK,Nov.24/PRNewswire/-...oodandDrugAdministration(FDA)hasacceptedforreviewE...pt®(donepezilHClextendedrelease)tabletsforthe...Thisnewhigherdoseformulationcontains23mgofdonepezi...verysystemthatallowsforgradualreleaseofthedrug.The...
Breaking Medicine Technology:Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3Government Stops Unlawful Social Security Suspensions 3B Agrees to Repay More Than Half a Billion in Back Benefits 54271 1Government Stops Unlawful Social Security Suspensions 3B Agrees to Repay More Than Half a Billion in Back Benefits 54271 2HearUSA Makes Hearing Aids and Care Available to AARP Members 54269 1HearUSA Makes Hearing Aids and Care Available to AARP Members 54269 2HearUSA Makes Hearing Aids and Care Available to AARP Members 54269 3HearUSA Makes Hearing Aids and Care Available to AARP Members 54269 4Noted Vertebroplasty Expert Cites Concerns About Recently Published Study 54266 1Noted Vertebroplasty Expert Cites Concerns About Recently Published Study 54266 2...Protective Antigen Anthrax Vaccine to be tested wi... SCOTTSDALE, Ariz., Aug. 7 ImmuneRegen,BioScienc...ldings, Inc.,(OTC Bulletin Board: IRBO), today ann...ent (MTA) with VaxGen Inc. (Pink Sheets: VXGN.PK)....e the pharmaceutically active,ingredient of VaxGen...
...7 Amicus Therapeutics,(Nasdaq: FOLD ), a biophar...y- delivered pharmacological chaperones for the tr... financial results for the second quarter,of 2007....h U.S. generally,accepted accounting principals (G...common stockholders per share of $1.37 for the thr...
Other Medicine Technology:ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc. 2ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc. 3ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc. 4Amicus Therapeutics Announces Second Quarter 2007 Financial Results 2Amicus Therapeutics Announces Second Quarter 2007 Financial Results 3Amicus Therapeutics Announces Second Quarter 2007 Financial Results 4Amicus Therapeutics Announces Second Quarter 2007 Financial Results 5Amicus Therapeutics Announces Second Quarter 2007 Financial Results 6Amicus Therapeutics Announces Second Quarter 2007 Financial Results 7Amicus Therapeutics Announces Second Quarter 2007 Financial Results 8ENDOLOOP Suture Type - 0 MONOCRYL
ENDOLOOP Ligature Type - 0 Chromic Gut
Bartels® C. Difficile Toxin A Antigen EIA with Controls
Clostridium Difficile Toxin A RAPYDTEST®
Medicine Products: